鱼腥草对无乳链球菌引起吉富罗非鱼肝脏损伤的修复作用

为探讨池塘种植鱼腥草对无乳链球菌引起吉富罗非鱼肝脏损伤的修复作用,在养殖池塘中分别种植0%(对照组)、5%、10%和15%池塘面积的鱼腥草,养殖90 d后进行无乳链球菌人工感染,分别在感染后0、24、48和72 h采集吉富罗非鱼肝脏,进行肝脏生化、抗氧化性能、组织病理和热休克蛋白70基因(HSP 70)表达研究。结果显示,感染后48和72 h对照组肝脏谷丙转氨酶(ALT)和谷草转氨酶(AST)活性最高,种植鱼腥草各组吉富罗非鱼肝脏ALT活性在感染前后均无显著性变化,感染后72 h,10%组吉富罗非鱼肝脏AST活性已恢复到感染前水平。抗氧化指标显示,种植鱼腥草能减缓链球菌感染引起吉富罗非鱼肝脏总抗氧化能力(T-AOC)下降,显著提高肝脏中超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、过氧化氢酶(CAT)和一氧化氮合酶(NOS)等抗氧化酶的活性,增加自由基清除能力,减少脂质过氧化丙二醛(MDA)的产生。组织病理学观察显示,对照组吉富罗非鱼感染后48 h肝窦明显淤血,肝索排列紊乱,肝细胞脂肪变性,而各种植鱼腥草组吉富罗非鱼在感染后仅表现为肝细胞明显嗜酸,肝窦轻度扩张。定量PCR结果显示,每组吉富罗非鱼肝脏HSP 70表达量在感染后都显著升高,感染后各时间点对照组吉富罗非鱼肝脏的HSP 70表达量均显著高于鱼腥草种植组。研究表明,种植鱼腥草能显著改善链球菌感染所造成的吉富罗非鱼肝脏AST和ALT上升,提高抗氧化应激能力,减轻链球菌感染引起的病理损伤;吉富罗非鱼通过肝脏HSP 70高表达促进受损蛋白质的早期修复与降解,种植鱼腥草具有抗炎作用和提高鱼体抵御病原菌的能力。     

不同罗非鱼品系感染无乳链球菌后对血液和肝胰腺生化指标的影响

为探究无乳链球菌(Streptococcus agalactiae)感染后对罗非鱼的血液和肝胰腺生化指标的影响，本研究以吉富罗非鱼(Oreochromis niloticus)抗病选育系F5代、奥尼罗非鱼(Oreochromis aureus × O. niloticus)、吉富罗非鱼“百桂”品系为对象，通过人工腹腔注射感染无乳链球菌，检测感染后不同时期肝胰腺和血液中的酸性磷酸酶(ACP)、碱性磷酸酶(AKP)、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)、总抗氧化能力(T-AOC)和溶菌酶(LZM)活性的变化。结果显示，奥尼罗非鱼、吉富罗非鱼抗病选育系F5代和吉富罗非鱼“百桂”品系的平均死亡率分别为55.4%、60.5%和78.6%，表明奥尼罗非鱼抗感染能力最强；3个品系感染无乳链球菌后，肝胰腺组织中的ACP、AKP、SOD和T-AOC酶活力均呈先升高后下降的趋势，其中，在感染后24 h，奥尼罗非鱼的AKP和CAT酶活力显著高于吉富罗非鱼抗病选育系F5代和吉富罗非鱼“百桂”品系；而感染后24 h，血清中ACP、AKP、LZM、CAT和T-AOC酶均显著升高，而SOD酶则下降，其中，奥尼罗非鱼的ACP、AKP、CAT和T-AOC酶活性明显高于吉富罗非鱼抗病选育系F5代和吉富罗非鱼”百桂”品系。综合比较6种酶在感染后不同时期的活性变化及3个品系的感染存活率，筛选出AKP和CAT作为评估罗非鱼抗无乳链球菌感染能力强弱的指标。     

无乳链球菌不同途径感染吉富罗非鱼后病原菌在体内的分布规律研究

为探讨无乳链球菌(Streptococcus agalactiae)感染罗非鱼(Oreochromis spp)的致病途径。采用腹腔注射、灌胃和浸泡三种方式对吉富罗非鱼进行无乳链球菌(HN016菌株)胁迫感染,利用平板活菌计数法统计三种方式感染后病原菌在体内组织的分布。注射和灌胃两种方式感染后均出现典型的链球菌感染发病症状,其中注射组在感染24 h后出现死亡高峰,死亡率为92.5%;灌胃组感染48 h后出现死亡高峰,死亡率为90%;而浸泡组,感染后均没有出现明显的发病症状,也没有出现死鱼。注射组和灌胃组在感染后2 h,其脾脏、肝脏、前肾、胃、腮、皮肤和肌肉组织中均可分离出病原菌,5 h后在脑组织中均可分离出病原菌,8 h后各组织分离出的病原菌数达到峰值;而浸泡组在感染8 h后才从各组织中分离出病原菌,且它们的数量均低于同时期的注射组和灌胃组。注射和灌胃两种方式可使吉富罗非鱼快速感染无乳链球菌而发病,而浸泡方式感染后病原菌虽可以侵入机体,但不表现出症状。由此,我们推测在自然条件下养殖的罗非鱼是通过口腔采食携带无乳,链球菌的食物而被感染。     

不同水温下无乳链球菌在尼罗罗非鱼体内的动态分布及其消除规律

本研究以腹腔注射无乳链球菌(Streptococcus agalactiae, WC1535菌株)后的尼罗罗非鱼(Oreochromis niloticus，GIFT strain)为研究对象，研究不同水温下无乳链球菌在尼罗罗非鱼体内的动态分布及消除规律。首先，分析25℃、29℃和33℃3个实验组罗非鱼的感染累积死亡率；其次，对3个实验组罗非鱼进行无乳链球菌的体外分离、培养和计数；然后，分析感染后不同实验组罗非鱼脑、肝脏、脾脏和肾脏组织中无乳链球菌的浓度。结果显示，随着水温的升高罗非鱼的累积死亡率也随之升高，25℃、29℃和33℃组的累积死亡率分别为6.67%、25.56%和78.90%。菌落统计结果显示，随着水温的升高，无乳链球菌在罗非鱼体内的增殖速度加快，同时，单位质量组织(脑、肝脏、脾脏和肾脏)中无乳链球菌的最大载菌量也随之升高。本研究还发现，无乳链球菌在罗非鱼脾脏中的浓度最高，在肾脏中的存活时间最长。综上可知，尼罗罗非鱼感染无乳链球菌后，体内各组织中链球菌的增殖、消除速度均与水温密切相关。本研究为研究无乳链球菌的致病机制奠定基础，也为通过合理调控水温及施药等措施防治尼罗罗非鱼链球菌病的暴发提供科学依据。     

海豚链球菌感染对不同品系罗非鱼血液生化指标和肝脏HSP70 mRNA表达的影响

以吉富罗非鱼、新吉富罗非鱼、埃及尼罗罗非鱼和红罗非鱼为研究对象,饲养100d后,进行海豚链球菌(2.95×108CFU/mL)感染试验,分析攻毒前后各品系罗非鱼的血液生化指标和肝脏HSP70 mRNA表达量的变化规律。另从各桶中取20尾鱼进行同样的攻毒试验,统计攻毒后各时间点的累积死亡率。结果表明,感染海豚链球菌96h后,吉富罗非鱼和新吉富罗非鱼对病原较为敏感,累积死亡率分别达到36.67%和38.33%;埃及尼罗罗非鱼对病原敏感性较差,试验期间未见死亡。吉富罗非鱼、新吉富罗非鱼和红罗非鱼血清皮质醇和葡萄糖水平以及肝脏HSP70 mRNA的表达量在攻毒后明显提高,血清谷丙转氨酶、谷草转氨酶与溶菌酶活力也呈上升趋势,碱性磷酸酶活力与甘油三酯和胆固醇水平低于攻毒前。埃及尼罗罗非鱼可以利用糖原和脂类产生的能量,提高了HSPS与一些特定免疫蛋白(溶菌酶、球蛋白等)的合成,增强了鱼体的非特异性免疫力。罗非鱼选育过程中,需要将抗病力与生长性能进行有效的结合,在注重生长速度的同时也要增强其抗应激能力,从而为罗非鱼产业的可持续发展提供保证。     

利用蛋白抗体芯片筛选盐胁迫下红罗非鱼鳃差异表达蛋白

为从蛋白角度探索红罗非鱼(Oreochromis mossambicus♀×O.niloticus♂)在盐胁迫环境下的调节适应机制,本研究采用蛋白抗体芯片结合串联质谱技术初步筛选了盐胁迫下红罗非鱼鳃组织的差异表达蛋白,并通过免疫组化和免疫印迹技术对候选差异蛋白进行了验证。结果显示,共筛选获得181个表达量有显著差异的蛋白质(变化倍数≥1.5),包含上调蛋白142个,下调蛋白39个。挑选5个蛋白进行质谱鉴定得到3个蛋白质:中间丝蛋白(intermediate filament protein,IF)、转运蛋白63(translocation protein 63,SEC63)、蛋白质二硫键异构酶A3(protein disulfide-isomerase A3,PDIA3)。免疫组化结果显示,在淡水、盐度组中,IF和PDIA3在鳃小片基部均有阳性反应,且随盐度升高,阳性反应呈先降低后增强的趋势,SEC63无阳性反应。Western blot结果显示,在淡水和盐度组中,IF和PDIA3两种蛋白均有表达,并且随盐度升高呈现先降低、再升高的变化趋势,SEC63蛋白无明显目的条带;在30盐度组中,胁迫早期,IF蛋白表达量降低,48 h达到最低值,72 h有明显回升,PDIA3蛋白表达量在胁迫后96 h显著升高(P0.05)。根据研究结果推测,IF和PDIA3是在盐胁迫环境下红罗非鱼鳃组织的响应蛋白,它们分别在细胞骨架、内质网功能维持中发挥重要调节作用。     

罗非鱼湖病毒核蛋白的克隆表达、抗体制备及其组织分布

近年来罗非鱼湖病毒(TiLV)在多个国家流行,对世界罗非鱼养殖业造成严重威胁。中国是罗非鱼第一养殖大国,尽管我国大陆还没有TiLV的正式报道,鉴于吉富罗非鱼是我国重要的罗非鱼养殖品种,其对TiLV的感染特性研究具有重要意义。本实验采用TiLV对吉富罗非鱼进行人工感染,随后在肝脏组织中克隆和测定了TiLV第6片段基因。罗非鱼湖病毒第6片段基因cDNA全长1044 bp,开放读码框(ORF)为954 bp,编码317个氨基酸,预测分子量为36.38 ku;5′非编码区(NCR)为19 bp,3′非编码区(NCR)为972 bp。系统进化树分析表明该蛋白属于TiLV核蛋白(NP)。随后在大肠杆菌中表达和提纯了GST融合NP蛋白,在新西兰大白兔上制备了多克隆抗体。通过酶联免疫吸附实验(ELISA)检测抗体效价为1∶51200,且抗体可特异性识别感染组织中的病毒NP蛋白。对吉富罗非鱼不同组织进行苏木精—伊红(H.E)染色观察,发现肝脏组织坏死并形成合胞体,脾脏部分细胞出现空泡、坏死,含铁血黄素增多,头肾细胞坏死,鳃丝上皮细胞明显解离脱落,鳃小片黏连,脑组织细胞肿大。通过蛋白印迹法(WB)和免疫组化(IHC)对人工感染TiLV的吉富罗非鱼不同组织进行检测,结果显示,NP蛋白在肝脏、脑、体肾和头肾等组织中均有表达,以肝脏组织中表达量最高。为了解吉富罗非鱼对TiLV的免疫反应,通过实时荧光定量PCR(qRT-PCR)测定免疫因子TNF-α和TGF-β在主要免疫器官脾脏和头肾组织中的表达。研究表明,在感染早期(感染后12~24 h),病毒可显著抑制TNF-α和TGF-β在脾脏和头肾中的表达,可能通过抑制宿主这些免疫因子来促进病毒自身早期的复制。本研究将为进一步解读TiLV的致病机理及其高效防控提供理论基础。     

无乳链球菌Sip-GAPDH嵌合核酸疫苗的制备及免疫效果评价

为了研究无乳链球菌Sip-GAPDH嵌合核酸疫苗对罗非鱼链球菌病的免疫保护作用,本研究通过PCR和重叠延伸拼接技术(SOEing)获得融合基因Sip-GAPDH,连接至真核表达载体pcDNA3.1(+)制备DNA疫苗,通过背鳍肌肉注射方式免疫吉富罗非鱼,免疫后第7、28天取样,采用PCR及RT-PCR方法检测pcDNA-Sip-GAPDH在各个组织(包括肌肉、脑、头肾、脾脏、鳃和肝脏)中的表达情况。采用ELISA、Real-time PCR法和体外攻毒法分别分析各实验组不同时间血清抗体效价、免疫基因(IgM、IL-1β和CD8)表达变化规律和相对保护率,研究该嵌合性疫苗对吉富罗非鱼的保护效果。结果显示,实验组在免疫接种第7和第28天时,注射点周围的肌肉、脑、头肾、脾脏、鳃和肝脏均能检测到嵌合性质粒,实验组罗非鱼血清抗体效价均高于对照组并于21 d时达到峰值(1∶4 096);qPCR数据表明,实验组鱼体胸腺、头肾和脾脏的IgM、IL-1β和CD8基因的mRNA表达量均出现了上调,并且在胸腺、头肾和脾脏中的表达量分别在免疫后第12和第48 h达到峰值;免疫后42 d进行人工攻毒后计算免疫保护率为93.3%。以上研究结果表明,本研究构建的无乳链球菌Sip-GAPDH嵌合核酸疫苗在罗非鱼链球菌病防治中具有潜在的应用价值。     

尼罗罗非鱼补体C9基因的克隆和组织表达分析

为了探究补体C9在尼罗罗非鱼(Oreochromis niloticus)免疫中发挥的作用,本研究克隆并分析了尼罗罗非鱼补体C9基因(OnC9)。结果显示:OnC9的cDNA序列全长2 502 bp,包含1 761 bp的开放阅读框(ORF),编码586个氨基酸。氨基酸序列同源性分析表明,OnC9与牙鲆(Paralichthys olivaceus)补体C9氨基酸相似性最高,达73.0%,与其他鱼类补体C9的相似性介于49.3%~71.4%之间。实时荧光定量PCR检测结果表明,OnC9基因在所检测的各个组织或器官中表达水平有明显差异,在肝脏中表达量最高,其次是肠道、后肾、皮肤、肌肉、鳃,在脑、脾脏、心脏、头肾、胸腺和血液中表达量最低。在无乳链球菌(Streptococcus agalactiae)感染鱼体后,肝脏、后肾等组织中OnC9表达量表现为在感染12 h、48 h(或36 h)、120 h先后出现三个峰值的波动表达的规律。说明OnC9在无乳链球菌感染尼罗罗非鱼后的免疫应答中发挥作用。     

尼罗罗非鱼Siglec-4b like基因的克隆与表达特性分析

从尼罗罗非鱼(Oreochromis niloticus)嗜中性粒细胞中克隆了唾液酸结合型免疫球蛋白凝集素Siglec-4b like基因,对其进行生物信息学分析,并利用实时荧光定量PCR检测:1)早期胚胎发育过程的表达;2)成鱼组织中的分布;3)人工感染无乳链球菌(Streptococcus agalactiae,GBS)后组织表达的变化。结果表明,尼罗罗非鱼Siglec-4b like具有与哺乳类Siglec-4相似的特异性结构域及保守氨基酸残基;早期胚胎发育Siglec-4b like基因在卵子中有一定表达量,受精后7 h即卵裂期表达上调,随后表达下降;Siglec-4b like基因在所检测的各组织中均有表达,鳃的表达量最高,其次是肌肉、皮肤、头肾和肠,其他组织的表达量较低;人工感染无乳链球菌后,Siglec-4b like在鳃、肾与肠等多个组织的表达均呈下调趋势。研究结果为进一步开展Siglec-4b like对罗非鱼免疫系统的调控作用及其与无乳链球菌免疫逃逸机制关系的研究奠定基础。     

BALB/c小鼠用于评价尼罗罗非鱼无乳链球菌毒力的研究

实验采用BALB/c小鼠作为实验动物,旨在建立尼罗罗非鱼无乳链球菌毒力测定的BALB/c小鼠模型。BALB/c小鼠经腹腔注射尼罗罗非鱼源无乳链球菌建立感染模型,比较了尼罗罗非鱼源无乳链球菌分别感染尼罗罗非鱼和小鼠的LD_(50)差异,分别测定了不同毒力尼罗罗非鱼无乳链球菌对尼罗罗非鱼和小鼠的毒力。结果显示,小鼠经腹腔注射无乳链球菌,在24 h内出现死亡现象,且对小鼠脑、肝脏、脾脏、肾脏等组织造成损伤。3次测定尼罗罗非鱼无乳链球菌TFJ0901对尼罗罗非鱼和小鼠LD_(50)分别为7.7×10~7、2.2×10~8、3.5×10~9 CFU/mL和405、361、419 CFU/只。将无乳链球菌TFJ0901和THN0901感染尼罗罗非鱼(1.0×10~7 CFU/mL)和小鼠(100 CFU/只),尼罗罗非鱼和小鼠存活率分别为100%、6.7%±5.8%和100%、0,其存活率都具有显著性差异。将无乳链球菌TFJ0901和TFJ-F感染尼罗罗非鱼(3.0×10~8 CFU/mL)和小鼠(2 500 CFU/只),尼罗罗非鱼的存活率分别为73.3%±11.5%和80.0%±10.0%,存活率差异不显著,小鼠存活率分别为13.3%±11.5%和100.0%,存活率具有显著性差异。研究表明,本实验成功建立了BALB/c小鼠作为尼罗罗非鱼源无乳链球菌毒力测定的稳定模型,测定不同毒力的尼罗罗非鱼源无乳链球菌对小鼠毒力与对尼罗罗非鱼毒力一致,且该模型能够区分尼罗罗非鱼模型难以区分的毒力相近的无乳链球菌。     

无乳链球菌感染尼罗罗非鱼的脑膜炎模型

目的：脑膜炎是罗非鱼无乳链球菌病的特征性临床症状,建立罗非鱼无乳链球菌脑膜炎模型,并制定相应的临床症状及组织病理学评分系统,对研究罗非鱼无乳链球菌病的致病机制具有十分重要的意义。方法：将健康罗非鱼43尾,随机分为4组：对照组(n=10)和试验组(n=33)。3组试验组根据不同感染剂量分为：10₆cfu组(n=11)、10₇cfu组(n=11)、10₈cfu组(n=11)。试验组分别将10₆、10₇、10₈CFU的无乳链球菌菌液腹腔注射罗非鱼复制脑膜炎模型。对感染罗非鱼的临床症状、剖检病变、脑组织(端脑、中脑、小脑、延脑)病理学进行判定,并结合细菌学检测,按照拟定的评分系统评价各组脑膜炎的造模效果,确定最佳造模方案。结果：各试验攻毒组罗非鱼感染后2天均出现不同程度死亡,未见明显神经症状。感染3天后鱼体开始出现异常活动的神经症状及突眼、角膜混浊等病理变化。病理组织学观察可见：蛛网膜下腔和脑软膜上有大量炎性渗出和染成蓝紫色微细颗粒的细菌团块,脑膜充血、水肿、疏松、增厚,有大量的中性白细胞等炎性细胞浸润；脑实质基质疏松水肿,呈海绵状；脑组织炎性细胞浸润,胶质细胞增生等软脑膜炎、脑膜脑炎症状。比较各组得分发现,10₇CFU组的无乳链球菌攻毒罗非鱼造模效果最好：临床症状显著而组内罗非鱼差异性最小,组织病理学观察患病罗非鱼病情和缓适中、利于观察研究。结论：使用10₇CFU无乳链球菌腹腔攻毒罗非鱼可在第3天成功构建脑膜炎模型,造模率为100%。     

尼罗罗非鱼表皮和鳃黏膜共生菌结构特征及其与鱼体健康状况相关关系

黏膜及其表面的共生菌群是鱼类抵御外界不利环境的第一道屏障。为探索养殖罗非鱼表皮和鳃黏膜共生菌菌群的结构特征是否与其健康状况间存在相关关系,本研究运用高通量测序技术,以无乳链球菌腹腔注射攻毒48 h后存活和濒死尼罗罗非鱼为检测对象,检测攻毒前后罗非鱼表皮和鳃黏膜共生菌群落结构差异。结果显示,健康尼罗罗非鱼表皮和鳃黏膜共生菌均存在优势菌群,主要为特吕珀菌属、硫杆菌属、弓形杆菌属、海单胞菌属和弧菌属。人工感染无乳链球菌后存活尼罗罗非鱼表皮和鳃黏膜共生菌菌群与感染前无显著差异;与存活组相比,濒死尼罗罗非鱼的表皮和鳃黏膜共生菌菌群多样性下降,其中弓形杆菌属、假交替单胞菌属、海单胞菌属、假单胞菌属和弧菌属等含量显著下降,链球菌属含量占总菌群的55.30%±1.24%,表明养殖尼罗罗非鱼表皮和鳃黏膜共生菌群落结构可能与其健康状况相关。     

Dietary Oil Sources on the Innate Immunity and Resistance of Nile Tilapia,Oreochromis niloticus,to Streptococcus agalactiae Challenge

The effect of different dietary oil sources on the innate immunity and resistance of Nile tilapia, Oreochromis niloticus, to Streptococcus agalactiae infection were evaluated. Fish were fed with diets containing different lipid sources (soybean oil [SO], corn oil, linseed oil [LO], fish oil [FO], and olive oil [OO]). Fish fed SO presented the highest (P < 0.05) hematocrit and serum protein. LO and FO diets increased (P < 0.05) the erythrocyte resistance to osmotic lysis in comparison with other treatments. Fish fed OO showed the highest (P < 0.05) iron‐binding capacity and the lowest serum lysozyme and bactericidal activities (P < 0.05). No difference (P > 0.05) was found between diets in alternative complement activity. Fish fed the SO diet had the highest (P < 0.05) survival rate against S. agalactiae challenge. In conclusion, diets with LO oil and FO, rich in ω‐3 fatty acids, and OO, rich in ω‐9 fatty acids, have an immunomodulatory effect in Nile tilapia juveniles. The use of SO in the Nile tilapia diet improved immune function and resistance against S. agalactiae.     

Comprehensive Investigation of Streptococcosis Outbreaks in Cultured Nile Tilapia,Oreochromis niloticus,and Red Tilapia,Oreochromis sp., of Thailand

Streptococcosis causes economic losses due to mass mortality at all culturing stages in Nile tilapia, Oreochromis niloticus, and red tilapia, Oreochromis sp., farming throughout Thailand. Diseased tilapia collected from outbreak areas during 2003–2012 were examined using histopathological, biochemical, and molecular tools. Infected fish showed clinical signs of septicemia, and bacteria were found in visceral organs. All gram‐positive cocci isolates were negative to catalase and oxidase, and exhibited β‐hemolysis; however, they possessed various biochemical profiles. PCR amplification of the 16S rRNA gene was used for 165 samples, and resulted in identification of 143 (86.67%) with Streptococcus agalactiae and 14 (8.48%) with Streptococcus iniae, and 8 (4.85%) with mixed infection. High similarity (≥98%) of 16S rRNA gene sequences to the reference strain S. agalactiae (accession no. EF092913) and S. iniae ATCC29178 type strain was observed in the typing of S. agalactiae and S. iniae from Thai farmed tilapia. This investigation documented that at least two species of streptococcal bacteria, S. agalactiae and S. iniae, were involved in tilapia streptococcal infection in Thailand. The molecular recognition of the etiologic agents showed that S. agalactiae was the dominant species that cause disease in all culture areas, whereas S. iniae were discovered only in cases from the northeastern and central regions.     

尼罗罗非鱼无乳链球菌Sip蛋白乳酸菌活载体口服疫苗的研制及其免疫效果

链球菌病是威胁我国罗非鱼养殖产业健康发展的重要病害之一。为研制出免疫效果好、操作简便的罗非鱼链球菌病疫苗,本研究构建重组表达无乳链球菌Sip蛋白的穿梭质粒pNZ8124-Sip,通过酶切和测序验证后电转化乳酸乳球菌NZ9000,获得能够诱导重组表达无乳链球菌Sip蛋白的乳酸菌活菌载体疫苗。采用SPS-PAGE电泳摸索最佳诱导浓度和诱导时间以获得最大表达量,通过镍柱纯化目的蛋白并进行Western blot检测;利用不同浓度的重组乳酸菌活载体疫苗灌胃口服免疫尼罗罗非鱼,采用间接ELISA法测定免疫后血清抗体水平变化,通过人工腹腔注射感染无乳链球菌获得相对免疫保护率。研究结果显示,构建的重组乳酸乳球菌可通过nisin诱导表达大小为48 ku特异性蛋白,与目的蛋白大小一致;PAGE电泳显示,重组蛋白主要以可溶蛋白和包涵体2种形式存在,其中胞内可溶性蛋白浓度达7.65 mg/mL;诱导表达的最佳条件为100 ng/mL nisin诱导6 h;Western blot检测结果显示,诱导蛋白可与鼠抗His标签抗体特异性结合。口服免疫结果显示,中浓度组(2.24×10~(10) CFU/mL)和低浓度组(2.24×10~9 CFU/mL)免疫2次能够显著提高尼罗罗非鱼的血清抗体水平和抗无乳链球菌感染能力,中浓度免疫组的相对免疫保护率最高为41.0%。本研究可为罗非鱼链球菌病口服疫苗的研究奠定基础,具有广阔的应用前景。     

Effect of <Emphasis Type="Italic">Cratoxylum formosum</Emphasis> on innate immune response and disease resistance against <Emphasis Type="Italic">Streptococcus agalactiae</Emphasis> in tilapia <Emphasis Type="Italic">Oreochromis niloticus</Emphasis>

The effect of aqueous extract of Cratoxylum formosum on innate immune response and disease resistance in tilapia Oreochromis niloticus was investigated. The fish were fed diets containing 0% (control), 0.5% (diet 1), 1% (diet 2), and 1.5% (diet 3) of C. formosum aqueous extract for 30 days. At the end of the experimental period, parameters of innate immune response including phagocytosis of blood leukocytes, lysozyme activity in plasma, and respiratory bust activity were examined. Feeding the fish with diet 2 and diet 3 for 20 days enhanced phagocytic activity and for 30 days stimulated lysozyme and respiratory burst activities. Diet 1 increased the phagocytic activity at 30 days, but did not affect the other measured parameters. All parameters were not significantly changed (P > 0.05) in the control group throughout the experiment. Following 30 days of feeding, fish were infected with S. agalactiae. The cumulative mortalities of bacterial-infected tilapia that were fed diet 1, diet 2, and diet 3 were 56, 12, and 10%, respectively, compared with 85% in the control group. These results indicate that the aqueous extract of C. formosum may elevate the innate immune response and enhance disease resistance in tilapia.     

Isolation and molecular characterization of streptococcal species recovered from clinical infections in farmed Nile tilapia (Oreochromis niloticus) in the Philippines

Streptococcosis cause severe losses for global tilapia farming, especially in developing countries. The aim of this study was to identify and characterize streptococci recovered from Nile tilapia farmed in the Philippines. Moribund and apparently healthy fish were sampled from grow-out cages, ponds and hatcheries. Clinical signs observed included exophthalmia, eye opacity, ascites, lethargy, erratic swimming and haemorrhages. Results showed that both Streptococcus iniae and Streptococcus agalactiae were associated with disease in these sites. Consistent with global reports, including those from South-East Asia, S. agalactiae was more widespread than S. iniae. Molecular serotyping of the S. agalactiae isolates identified the serotype Ia and serotype Ib. Histopathological findings were meningitis, meningoencephalitis and septicaemia. Identical virulence profiles were found for all strains of S. iniae, while S. agalactiae strains were separated into virulence profile I and profile II. All strains were susceptible to the tested antibiotics and resistant to oxolinic acid. Only S. agalactiae serotype Ib showed resistance to sulphamethoxazole–trimethoprim. This is the first study from the Philippines to characterize the streptococci involved in disease outbreaks in tilapia aquaculture. Outputs from this study will promote the development of efficacious disease control strategies in tilapia farming for the Philippines and South-East Asia.     

Streptococcosis,Lactococcosis and Enterococcosis are potential threats facing cultured Nile tilapia (Oreochomis niloticus) production

Streptococcosis, lactococcosis and enterococcosis are among the most important bacterial diseases affecting tilapia farms in Kafr Elsheikh governorate, Egypt. A number of clinically diseased fish were collected and submitted to our laboratory during disease outbreak in 2018. They were characterized by nervous swimming behaviour, skin darkness, exophthalmia, ocular opacity and haemorrhages. Necropsy findings were splenomegaly, congestive hepatomegaly, liquefied brain and enteritis. The phenotypic and molecular characterizations of the bacterial strains isolated from naturally infected fish identified three genera of Gram‐positive cocci: Streptococcus agalactiae, Enterococcus faecalis and Lactococcus garvieae. Infectivity trials were conducted in four groups of Nile tilapia inoculated with S. agalactiae Egy‐1, E. faecalis Egy‐1 and L. garvieae Egy‐1 strains and saline. Mortalities, clinical signs and pathological findings were recorded daily 14 days post infection. Experimentally infected tilapia showed similar clinical signs, postmortem lesions, but varied in the severity and experienced high mortalities up to 70% in case of S. agalactiae and L. garvieae infections and 30% in case of E. faecalis infection. Pathological examination of infected tissue sections stained with modified Brown–Brenn and immunohistochemistry revealed an important direct correlation between the distribution of each bacterial isolate and the lesions developed in different organs. Furthermore, the isolates were subjected to profiling against 11 antibiotics, and they showed resistance against several types of antibiotics, which implicate potential risk to human health and emphasize the urgent need for alternate bio‐control strategies to prevent the diseases and the problem of multidrug resistance in aquatic environment.